Lipid-associated macrophages are induced by cancer-associated fibroblasts and mediate immune suppression in breast cancer
…, D Meseure, A Vincent-Salomon, A Tardivon, E Laas… - Cancer research, 2022 - AACR
This work identifies a novel lipid–associated macrophage subpopulation with immune
suppressive functions, offering new leads for therapeutic interventions in triple-negative breast …
suppressive functions, offering new leads for therapeutic interventions in triple-negative breast …
[HTML][HTML] COVID-19 in breast cancer patients: a cohort at the Institut Curie hospitals in the Paris area
…, A Bellesoeur, V Servois, D Hequet, E Laas… - Breast Cancer …, 2020 - Springer
Background Cancer patients have been reported to be at higher risk of COVID-19 complications
and deaths. We report the characteristics and outcome of patients diagnosed with …
and deaths. We report the characteristics and outcome of patients diagnosed with …
Trends in the rate of invasive procedures after the addition of the intrauterine tamponade test to a protocol for management of severe postpartum hemorrhage
E Laas, C Bui, T Popowski, OM Mbaku… - American journal of …, 2012 - Elsevier
OBJECTIVE: The purpose of this study was to investigate changes in invasive procedure
rates after the addition of intrauterine balloon tamponade as an initial second-line therapy to …
rates after the addition of intrauterine balloon tamponade as an initial second-line therapy to …
Preterm birth and congenital heart defects: a population-based study
BACKGROUND AND OBJECTIVES: Preterm birth (PTB) and congenital heart defect (CHD)
are 2 major causes of mortality and disability of perinatal origin. There are limited data on the …
are 2 major causes of mortality and disability of perinatal origin. There are limited data on the …
[HTML][HTML] Nivolumab plus chemoradiotherapy in locally-advanced cervical cancer: the NICOL phase 1 trial
…, L Bazire, C Durdux, V Fourchotte, E Laas… - Nature …, 2023 - nature.com
Concurrent chemoradiotherapy (CRT) with blockade of the PD-1 pathway may enhance
immune-mediated tumor control through increased phagocytosis, cell death, and antigen …
immune-mediated tumor control through increased phagocytosis, cell death, and antigen …
[HTML][HTML] Prognostic value of the Residual Cancer Burden index according to breast cancer subtype: Validation on a cohort of BC patients treated by neoadjuvant …
AS Hamy, L Darrigues, E Laas, D De Croze, L Topciu… - PloS one, 2020 - journals.plos.org
Introduction The Residual Cancer Burden (RCB) quantifies residual disease after neoadjuvant
chemotherapy (NAC). Its predictive value has not been validated on large cohorts with …
chemotherapy (NAC). Its predictive value has not been validated on large cohorts with …
Lymphovascular invasion after neoadjuvant chemotherapy is strongly associated with poor prognosis in breast carcinoma
AS Hamy, GT Lam, E Laas, L Darrigues… - Breast Cancer Research …, 2018 - Springer
Purpose Few studies evaluated the prognostic value of the presence of lymphovascular
invasion (LVI) after neoadjuvant chemotherapy (NAC) for breast cancer (BC). Methods The …
invasion (LVI) after neoadjuvant chemotherapy (NAC) for breast cancer (BC). Methods The …
Interaction between molecular subtypes and stromal immune infiltration before and after treatment in breast cancer patients treated with neoadjuvant chemotherapy
AS Hamy, H Bonsang-Kitzis, D De Croze, E Laas… - Clinical Cancer …, 2019 - AACR
Purpose: High levels of tumor-infiltrating lymphocytes (TIL) before neoadjuvant chemotherapy
(NAC) are associated with higher pathologic complete response (pCR) rates and better …
(NAC) are associated with higher pathologic complete response (pCR) rates and better …
Tumor size, an additional prognostic factor to include in low-risk endometrial cancer: results of a French multicenter study
G Canlorbe, S Bendifallah, E Laas, E Raimond… - Annals of surgical …, 2016 - Springer
Background Additional tools are needed to improve the selection of women with early-stage
endometrial cancer (EC) at increased risk of nodal metastases and/or recurrence to adapt …
endometrial cancer (EC) at increased risk of nodal metastases and/or recurrence to adapt …
Oncologic outcomes of endometrial cancer in patients with low-volume metastasis in the sentinel lymph nodes: an international multi-institutional study
Objective To assess oncologic outcomes in endometrial cancer patients with low-volume
metastasis (LVM) in the sentinel lymph nodes (SLNs). Methods Patients with endometrial …
metastasis (LVM) in the sentinel lymph nodes (SLNs). Methods Patients with endometrial …
